GlobeNewswire (Feb 7, 2013)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
51 people get NKBP articles and Market Currents by email alert.
Get email alerts on NKBP »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
GlobeNewswire (Jan 29, 2013)
-
GlobeNewswire (Jan 15, 2013)
-
GlobeNewswire (Jan 14, 2013)
-
GlobeNewswire (Dec 14, 2012)
-
GlobeNewswire (Nov 25, 2012)
-
GlobeNewswire (Nov 5, 2012)
-
-
China Nuokang Bio-Pharmaceutical Inc. Enters Into Definitive Agreement for Going Private TransactionGlobeNewswire (Sep 27, 2012)
-
GlobeNewswire (Aug 22, 2012)
-
GlobeNewswire (Aug 1, 2012)
-
ShangPharma Going PrivateMarkus Aarnio • Mon, Jul 9, 2012 -
-
GlobeNewswire (Jun 15, 2012)
-
GlobeNewswire (May 23, 2012)
-
GlobeNewswire (May 10, 2012)
-
GlobeNewswire (May 9, 2012)
To learn more about Seeking Alpha Pro, click here.
-
-
ShangPharma Going PrivateMarkus Aarnio • Mon, Jul 9, 2012
-
-
-
-
How ADR Small Caps Can Lower Risk And Boost ProfitsKurtis Hemmerling • Wed, Oct 19, 2011 -
-
6 Undervalued Healthcare Stocks With Impressive ProfitabilityKapitall • Wed, Sep 14, 2011
-
-
Maverick Capital Focuses on Tech and Health StocksMarket Folly • Mon, Feb 22, 2010 -
-
China Biotech Week in Review: Year-End IPOsChinaBio Today • Mon, Jan 4, 2010
-
-
-
Making and Breaking Biotech DealsThe Burrill Report • Mon, Dec 14, 2009 -
Four of Eight Planned IPOs Complete DealsRenaissance Capital IPO Research • Sun, Dec 13, 2009 -
-
There are no Transcripts on NKBP.
-
GlobeNewswire (Feb 7, 2013)
-
GlobeNewswire (Jan 29, 2013)
-
GlobeNewswire (Jan 15, 2013)
-
GlobeNewswire (Jan 14, 2013)
-
GlobeNewswire (Dec 14, 2012)
-
GlobeNewswire (Nov 25, 2012)
-
GlobeNewswire (Nov 5, 2012)
-
at MarketWatch.com (Sep 27, 2012)
-
China Nuokang Bio-Pharmaceutical Inc. Enters Into Definitive Agreement for Going Private TransactionGlobeNewswire (Sep 27, 2012)
-
GlobeNewswire (Aug 22, 2012)
-
GlobeNewswire (Aug 1, 2012)
-
GlobeNewswire (Jun 15, 2012)
-
GlobeNewswire (May 23, 2012)
-
GlobeNewswire (May 10, 2012)
-
at MarketWatch.com (May 9, 2012)
-
GlobeNewswire (May 9, 2012)
-
GlobeNewswire (Mar 14, 2012)
NKBP vs. ETF Alternatives
Company Description
Currently, there's no company description for NKBP.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Tuesday, January 29, 3:39 PM China Nuokang Bio-Pharmaceutical (NKBP +9.1%) trades higher today after announcing that it will reconvene its extraordinary general meeting of shareholders to discuss merger plans that was previously adjourned on January 15, 2013. Comment! [Healthcare, Global & FX, M&A]
-
- View all 2 replies
-
cosimo: In China there are companies have greater capital resources, research and development personnel, experience at conducting clinical trials. -
valueforSEC: nel 2009 la S.E.C. ha valutato 0,0005 dollari a share di NKBP Cinesi hanno offerto ordinary share of NKBP a 10 dollari, tu cosa ne pensi?
LATEST REPLIES
-
- View all 2 replies
-
cosimo: In China there are companies have greater capital resources, research and development personnel, experience at conducting clinical trials.
-
valueforSEC: nel 2009 la S.E.C. ha valutato 0,0005 dollari a share di NKBP Cinesi hanno offerto ordinary share of NKBP a 10 dollari, tu cosa ne pensi?